Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 317,716 shares of BLFS, which is worth approximately $7.73 Million. The most recent transaction as insider was on Sep 28, 2023, when has been sold 659 shares (Common Stock) at a price of $14.16 per share, resulting in proceeds of $9,331. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 318K
0.24% 3M change
16.33% 12M change
Total Value Held $7.73 Million

Aby J. Mathew Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 28 2023
SELL
Open market or private sale
$9,331 $14.16 p/Share
659 Reduced 0.24%
273,121 Common Stock
Sep 24 2023
BUY
Grant, award, or other acquisition
-
802 Added 0.29%
273,780 Common Stock
Sep 10 2023
BUY
Grant, award, or other acquisition
-
792 Added 0.29%
272,978 Common Stock
Aug 27 2023
BUY
Grant, award, or other acquisition
-
966 Added 0.35%
272,186 Common Stock
Aug 25 2023
SELL
Open market or private sale
$5,703 $10.99 p/Share
519 Reduced 0.19%
271,220 Common Stock
Aug 14 2023
SELL
Open market or private sale
$2,228 $12.38 p/Share
180 Reduced 0.07%
271,739 Common Stock
Jul 20 2023
SELL
Open market or private sale
$200,700 $20.07 p/Share
10,000 Reduced 3.55%
271,919 Common Stock
Jul 20 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.43%
281,919 Common Stock
Jul 19 2023
SELL
Open market or private sale
$204,600 $20.46 p/Share
10,000 Reduced 3.55%
271,919 Common Stock
Jul 19 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.43%
281,919 Common Stock
Jun 27 2023
SELL
Open market or private sale
$15,922 $22.91 p/Share
695 Reduced 0.25%
271,919 Common Stock
Jun 22 2023
SELL
Open market or private sale
$233,200 $23.32 p/Share
10,000 Reduced 3.54%
272,614 Common Stock
Jun 22 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.42%
282,614 Common Stock
Jun 21 2023
SELL
Open market or private sale
$229,700 $22.97 p/Share
10,000 Reduced 3.54%
272,614 Common Stock
Jun 21 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.42%
282,614 Common Stock
May 31 2023
SELL
Open market or private sale
$11,697 $23.21 p/Share
504 Reduced 0.18%
272,614 Common Stock
May 25 2023
SELL
Open market or private sale
$223,299 $22.33 p/Share
10,000 Reduced 3.53%
273,118 Common Stock
May 25 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.41%
283,118 Common Stock
May 24 2023
SELL
Open market or private sale
$221,400 $22.14 p/Share
10,000 Reduced 3.53%
273,118 Common Stock
May 24 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.41%
283,118 Common Stock
May 15 2023
SELL
Open market or private sale
$2,338 $18.71 p/Share
125 Reduced 0.05%
273,118 Common Stock
Apr 20 2023
SELL
Open market or private sale
$192,500 $19.25 p/Share
10,000 Reduced 3.59%
268,352 Common Stock
Apr 20 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.47%
278,352 Common Stock
Apr 19 2023
SELL
Open market or private sale
$194,700 $19.47 p/Share
10,000 Reduced 3.59%
268,352 Common Stock
Apr 19 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.47%
278,352 Common Stock
AJM

Aby J. Mathew

EVP & Chief Scientific Officer
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS